Ambu A/S Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
August 25, 2022 at 02:00 am EDT
Share
Ambu A/S reported earnings results for the third quarter and nine months ended June 30, 2022. For the third quarter, the company reported sales was DKK 1,128 million compared to DKK 973 million a year ago. Net income was DKK 28 million compared to DKK 62 million a year ago. Basic earnings per share from continuing operations was DKK 0.11 compared to DKK 0.24 a year ago. Diluted earnings per share from continuing operations was DKK 0.11 compared to DKK 0.24 a year ago.
For the nine months, sales was DKK 3,281 million compared to DKK 2,987 million a year ago. Net income was DKK 223 million compared to DKK 248 million a year ago. Basic earnings per share from continuing operations was DKK 0.88 compared to DKK 0.99 a year ago. Diluted earnings per share from continuing operations was DKK 0.88 compared to DKK 0.98 a year ago.
Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows:
- single-use endoscopes (56.3%);
- emergency care and resuscitation devices (22.9%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers;
- monitoring and diagnostic devices (20.8%): including electrodes used in the fields of cardiology, neurophysiology and first aid.
At the end of September 2023, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico.
Net sales are distributed geographically as follows: Denmark (1.2%), Europe (37.8%), the United States (49.5%), North America (1.3%) and other (10.2%).